Unjoni Ewropea -
Iżlandiż -
EMA (European Medicines Agency)
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - Æxlishemjandi lyf - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 40 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 40 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
glimeryl tafla 1 mg
teva b.v.* - glimepiride - tafla - 1 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
glimeryl tafla 2 mg
teva b.v.* - glimepiride - tafla - 2 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
glimeryl tafla 3 mg
teva b.v.* - glimepiride - tafla - 3 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
glimeryl tafla 4 mg
teva b.v.* - glimepiride - tafla - 4 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 1 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 1 mg/ml
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 10 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 10 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 20 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 20 mg